107027-47-4 Usage
Quinoline carboxylic acid class
Organic compound class This refers to the classification of the compound within the larger group of organic compounds, specifically within the quinoline carboxylic acid category.
Pharmaceutical applications
Potential use in drug development The compound has potential applications in the pharmaceutical industry, particularly for the development of new drugs.
Antimicrobial properties
Ability to fight infections The compound exhibits antimicrobial activity, making it a potential candidate for treating infectious diseases.
Anti-inflammatory properties
Reduction of inflammation The compound also has anti-inflammatory properties, which could be useful in treating inflammatory conditions.
Enzyme and pathway inhibition
Mechanism of action The compound's ability to inhibit certain enzymes and pathways contributes to its potential therapeutic effects.
Importance in medicinal chemistry
Subject of study for drug design The compound's molecular structure and properties make it an important subject of study in the field of medicinal chemistry, particularly for drug design and development.
Check Digit Verification of cas no
The CAS Registry Mumber 107027-47-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,7,0,2 and 7 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 107027-47:
(8*1)+(7*0)+(6*7)+(5*0)+(4*2)+(3*7)+(2*4)+(1*7)=94
94 % 10 = 4
So 107027-47-4 is a valid CAS Registry Number.
InChI:InChI=1/C18H15NO3/c1-11-4-3-5-14-15(18(20)21)10-16(19-17(11)14)12-6-8-13(22-2)9-7-12/h3-10H,1-2H3,(H,20,21)
107027-47-4Relevant articles and documents
Potential antitumor agents. 57. 2-Phenylquinoline-8-carboxamides as 'minimal' DNA-intercalating antitumor agents with in vivo solid tumor activity
Atwell,Baguley,Denny
, p. 396 - 401 (2007/10/02)
A series of phenyl-substituted derivatives of the 'minimal' DNA-intercalating agent N-[2-(dimethylamino)-ethyl]-2-phenylquinoline-8-carboxamide (1) have been synthesized and evaluated for in vivo antitumor activity, in a continuing search for active compo
